Evidence map›Paper›PMID 41680936›Full record

ArticleActa neuropathologica communications2026

Neurons differentially upregulate type 2 immune cytokines and interleukin-4 receptor subtypes during neuroinflammation.

Micaela Domingues, Yvonne Gärtner, Nicholas Hanuscheck, Samantha Schmaul, Frauke Zipp, Christina Francisca Vogelaar

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Micaela Domingues *Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn 2 ), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Yvonne Gärtner *Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn 2 ), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Nicholas HanuscheckDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn 2 ), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Samantha SchmaulDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn 2 ), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Frauke ZippDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn 2 ), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Christina Francisca VogelaarDepartment of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn 2 ), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. tineke.vogelaar@unimedizin-mainz.de.ORCID 0000-0002-9683-7336

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although numerous studies demonstrate beneficial effects of exogenous interleukin-4 (IL-4) in different central nervous system (CNS) disease models, little is known about the expression of IL-4 and its receptor (IL-4R) system in neurons. We previously showed that the beneficial effects of exogenous IL-4 in neuroinflammation depend on functional neuronal IL-4Rα. Here, we demonstrate neuronal expression of IL-4Rα, the receptor co-chains IL-2Rγ (IL-4R type I) and IL-13Rα1 (IL-4R type II), as well as the type 2 immune cytokines IL-4 and IL-13 throughout the brain and spinal cord of healthy mice and of mice subjected to experimental autoimmune encephalomyelitis (EAE). Surprisingly, we observed differential expression of the receptor chains in different regions of the CNS, with forebrain neurons expressing mainly IL-4R type II and spinal cord neurons showing prominent IL-2Rγ signals (IL-4R type I), the latter mainly known in immune cells. Moreover, we found that the regulation of the system was mainly driven by the increase of IL-4Rα-expressing neurons at the peak of neuroinflammation, whereas the co-chains are downregulated. Additionally, we showed neuronal expression of IL-4 and IL-13 throughout the CNS and observed upregulation of these cytokines during neuroinflammation. Our data indicate that neurons upregulate both IL-4Rα and its ligands during neuroinflammation.

Indexed as

BrainCytokinesEncephalomyelitis, Autoimmune, ExperimentalInterleukin-13Interleukin-4Neuroinflammatory DiseasesNeuronsReceptors, Interleukin-4AnimalsFemaleInterleukin-4 Receptor alpha SubunitMiceMice, Inbred C57BLSpinal CordUp-RegulationCytokinesInterleukin-13Interleukin-4Interleukin-4 Receptor alpha SubunitReceptors, Interleukin-4Central nervous systemExperimental autoimmune encephalomyelitisInterleukin-13 receptor alpha 1Interleukin-2 receptor gammaInterleukin-4 receptorNeuroinflammationNeuronalType 2 immune cytokines

Identifiers

PMID41680936
PMCPMC13040743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.